SCHEMBL10412160

SCHEMBL10412160

COc1ccc(CCc2ccc(NC(=O)C3=C(O)c4cc(Cl)ccc4SC3)cc2)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 1/20 0.50
▸ LMNA P02545 1/20 0.46
▸ TP53 P04637 3/20 0.45
▸ GAA P10253 2/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPT P10636 6/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ POLB P06746 1/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ DNMT3A Q9Y6K1 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10411986 0.91 MAPT (0.50) CNR1TP53GAAALDH1A1MAPT
SCHEMBL10412947 0.89 MAPT (0.50) CNR1LMNATP53MAPTSMN1; SMN2
SCHEMBL10411974 0.82 MAPT (0.43) TP53GAAMAPTPOLBALOX15
SCHEMBL10411288 0.79 MAPT (0.47) CNR1LMNATP53ALDH1A1MAPT
SCHEMBL10412049 0.77 CCR5 (0.54) TP53MAPTALOX15
SCHEMBL10483445 0.77 MAPT (0.48) LMNATP53MAPTSMN1; SMN2MEN1
SCHEMBL10386151 0.77 ALOX15 (0.71) CNR1LMNATP53GAAALDH1A1
SCHEMBL10411293 0.76 PTGES (0.42) CNR1TP53GAAMAPTMEN1
SCHEMBL10411296 0.76 ALOX15 (0.57) ALOX15
SCHEMBL10412491 0.76 NAMPT (0.41) CNR1LMNATP53ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US claimed
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US disclosed
US-4874758-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-10-17 — — US disclosed
US-4868195-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868200-A LEUKOTRIENES, LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868205-A ANTIALLERGENS, ANTIINFLAMMATORY, CARDIOVASCULAR DISORDERS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868199-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4761424-A Enolamides, pharmaceutical compositions and methods for treating inflammation WARNER-LAMBERT COMPANY (US) 1988-08-02 — — US disclosed
EP-0221345-A1 Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP disclosed
Send feedback